AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

Surufatinib, an oral angioimmuno kinase inhibitor, is approved for treating inoperable or late-stage, low-grade (G1 and G2), well-differentiated pNETs and extrapancreatic neuroendocrine tumors. This ...

BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are uncommon and heterogeneous neoplasms, often exhibiting indolent biological behavior. Their incidence is rising, largely due to the widespread ...

A new study analyzing nearly 200,000 U.S. cases from 2016 to 2020 found that men are more than twice as likely to die from "broken heart syndrome"—medically known as Takotsubo cardiomyopathy—compared ...

A new study finds men have twice the death rate from 'broken heart syndrome' compared to women. Researchers warn of the serious risks and call for better treatment options. Listen to Story Men have an ...

Summary: A large-scale U.S. study reveals that Takotsubo cardiomyopathy—also known as broken heart syndrome—continues to carry a high ... heart attack and primarily affects older women, though men ...

Listen below (skip to 5:30 for this one): New research published by the Journal of the American Heart Association has found that men are more likely to die from ‘broken heart syndrome ...

Men are more likely to die from "broken heart syndrome" than women are, according to a new study published. Takotsubo Cardiomyopathy, also known as broken heart syndrome, is brought on by physical ...

Men are more than twice as likely to die from broken heart syndrome than women, according to a new study. Broken heart syndrome, also known as takotsubo cardiomyopathy, is a sudden weakness in the ...